Mettler-Toledo International, I (MTD) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Mettler-Toledo International, I

NYSE•Healthcare•Diagnostics & Research

$1,410.44+31.75(0.02%)After hours

Market Cap

$28.27B

P/E

21.9x

P/S

4.7x

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.

How this company scores

WeakMetricSide Score: 56/100

Grade capped at D — Negative equity — the balance sheet is insolvent. Strongest: Growth (17/25); weakest: Balance Sheet & Red Flags (12/25).

Profitability14/25

Growth17/25

Balance Sheet & Red Flags12/25

Cash & Earnings Quality13/25

Strengths

Strong marginsInterest easily coveredProfit converts from growthNo share dilution

Grade capped at D

Negative equity — the balance sheet is insolvent.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 21.9x5y range 16.0x – 50.7x

Currently below its 20-quarter median.

P/S · 4.7x5y range 3.4x – 10.5x

Currently near its 20-quarter median.

P/B · 1311.3x5y range 41.8x – 1311.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Revenue Decline

Red Flag

TTM revenue has contracted 25.7% — significant decline indicating deteriorating demand.

Price & Volume

Market Cap $28.27B

Metrics at a Glance

as of March 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $6.02B
Q. Revenue: $947.13M
TTM EBITDA: $1.65B
TTM Op. Income: $1.55B
Q. Op. Income: $202.33M
TTM Net Income: $1.29B
Q. Net Income: $169.45M
EPS: $8.35
Shares Out.: $20.29M

$6.02B in TTM revenue grew 6.1% YoY, reaching $947.13M last quarter. TTM EBITDA of $1.65B and TTM operating income of $1.55B show growth is flowing through to the bottom line. TTM net income of $1.29B means revenue is converting into profit. Over the past year, TTM revenue is up 6% — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 58.7%
EBITDA Margin: 22.8%
Op. Margin: 21.4%
Net Margin: 17.9%

Op. margin of 21.4% is down 5.6% YoY — costs are rising relative to revenue. Net margin at 17.9% and gross margin of 58.7% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has fallen for 3 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 21.9x
P/S Ratio: 4.7x
P/B Ratio: N/A

At 21.9x P/E, the stock trades within typical market levels. P/S of 4.7x and P/B of 0.0x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 17% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.67B
Cash: $60.57M
Long-Term Debt: $2.16B
Book Value: $-41.88M
D/E Ratio: N/A
Debt/EBITDA: 10.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $139.79M
TTM Free Cash Flow: $531.37M
FCF Margin: 8.8%
FCF / Net Income: 0.4

TTM FCF of $531.37M on $139.79M in operating cash flow. The FCF / Net Income ratio of 0.4x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has fallen for 4 consecutive quarters — a weakening trend.